Deep Dive

Market Access

Integrating market access considerations into biopharmaceuti...

The biopharmaceutical industry operates at the intersection of health innovation and market viability, where the significance of integrating market access insights into investment decisions

Market Access

illustration of person walking from above

Chasing the holy grail of value-based healthcare

Patients, healthcare professionals, payers, and other stakeholders can have vastly different views on the value of a particular product, often resulting in a struggle between prioritising a

Market Access

Rare diseases: the urgent need for health equity and acceler...

Rare diseases are complex, but the need is urgent. Alexion’s Eunice Alvazzi discusses the shared responsibility in achieving access to innovation in rare diseases

Market Access

The biosimilars dance: How drugmakers game the US patent sys...

When the primary patent on a blockbuster drug expires, affordable generic or biosimilar competition is expected to balance the market, offering relief to patients who could not afford the h

Market Access